Transcend: девять шагов на пути к вечной жизни

1. Bielak A. A., Hughes T. F., Small B. J., Dixon R. A. (2007) It’s never too late to engage in lifestyle activities: significant concurrent but not change relationships between lifestyle activities and cognitive speed // Gerontol B Psychol Sci Soc Sci Nov; 62 (6): P331–339.

2. Lydic R., McCarley R. W., Hobson J. A. (1984) Forced activity alters sleep cycle periodicity and dorsal raphe discharge rhythm. Am J. Physiol 247 (1 Pt 2): R135–145. Stanford Report, “Remediation training improves reading ability of dyslexic children,” February 25, 2003 .

3. McDaniel M. A. (2003) Brain-specific nutrients: a memory cure // Nutrition 11–12: 957–975.

4. Bower, B. (1998) To dream, perchance to scan // Science News 153: 44.

Глава 2. Как поддержать работу сердца…

1. Liem A. H., Jukema J. W., van Veldhuisen D. J. (2003) Secondary prevention in coronary heart disease patients with low HDL: What options do we have? // Int J. Cardiol 90 (1): 15–21.

2. National Center for Health Statistics, “Deaths – leading causes,” cdc.gov/nchs/FASTATS/lcod.htm.

3. Lagergvist B., James S., Stenestrand U., Lindback M., Nilsson T., Wallentin L. (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden // NEJM 356 (10): 1009–1019.

4. Enos W. F, Holmes R. H, Beyer J (1953) Coronary disease among United States soldiers killed in action in Korea // JAMA 152: 1090–1093.

5. The Society for Women’s Health Research, “What really claims women’s lives?” womenshealthresearch.org/site/PageServer?pagename=hs_whatclaims.

6. Becker D., Gordon R., Morris P., Yorko J., Gordon J., Li M., Iqbal N. (2008) Simvastatin vs therapeutic lifestyle changes and supplements: Randomized primary prevention trail // Mayo Clin Proc 83: 758–764.

7. Lu Z., Kou W., Du B., Wu Y., Zhao S., Brusco O., Morgan J., Capuzzi D. (2008) Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction // Amer J. of Card 12 (101): 1689–1693.

8. Gouni-Berthold J., Berthold H. (2002) Policosanol: Clinical pharmacology and therapeutic significance of a new lipid-lowering agent // Amer Heart J. 143 (2): 356–365.

9. Morike E. M. (1996) Vitamin E treatment of patients with coronary disease // Deutsch Med Wochenschr May, 121 (21): A9.

10. Brook J. G., Linn S., Aviram M. (1986) Phosphatidlylinositol raises HDL cholesterol levels in humans // Biochem Med Metabol Biol (35): 31–39.

11. Katsuyuki M., Daviglus M. L., Dyer A. R., Kiang L., Garside D. B., Stamler J., Greenland P. (2001) Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: The Chicago Heart Association detection project in industry // Arch Intern Med 161: 1501–1509.

12. Bolotin H. H. (2007) DXA in vivo BMD methodology: An erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling // Bone 41 (1): 138–154.

Глава 3. Пищеварение

1. Drossman D. A., Li Z., Andruzzi E., Temple R. D., Talley N. J., Thompson W. G., Whitehead W. E., Janssens J., Funch-Jensen P., Corazziari E. et al. (1993) U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodermography, and health impact // Digestive Disease Science 38 (9): 1569–1580.

2. Krasinski S. D., Russell R. M., Samloff I. M., Jacob R. A., Dallal G. E., McGandy R. B., Hartz S.C. (1986) Fundic atrophic gastritis in an elderly population // J. Am Geriatr Soc 34 (11): 800–806.

3. Scrimshaw N. S., Murray E. B. (1988) The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance // Am J. Clin Nutr 48 (Suppl 4): 1079–1159.

4. Swagerty D. L. Jr, Walling A. D., Klein R. M. (2002) Lactose intolerance // Amer Fam Physician 65 (9): 1845–1850.

Глава 4. Оптимизация гормонального фона

1. Canaris G. J., Manowitz N. R., Mayor G., Ridgeway E. G. (2000) The Colorado thyroid prevalence study // Arch of Int. Med (160): 526–534.

2. Svec F., Porter J. R. (1998) The actions of exogenous dehydroepiandrosterone in experimental animals and humans // Proceedings of the Society for Exp Bio and Med (218): 174–191.

3. Lemon J. A., Boreham D. R., Rollow C. D. (2003) A dietary supplement abolishes age-related cognitive decline in transgenic mice expressing elevated free radical processes // Exp Bio Med. (228): 800–810.

4. Butler R. N., Fossel M., Mitchell H., Heward C. B., Olshansky S. J., Perls T. T., Rothman D. J., Rothman S. M., Warner H. R., West M. D., and Wright W.F. (2002) Is there an anti-aging medicine? // J. of Gerontology Series A: Bio SciMed Sci (57): B333-B3385.

5. Straub R. H., Lehle K., Herfarth H., Weber M., Falk M. W., Preuner J., Scholmerich J. (2002) Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: Role of interleukin-6 and tumour necrosis factor // Eur J. Endo 146: 365–374.